ABSTRACT
Covid 19 is an illness caused by the recently discovered Coronavirus. The virus causes an unparalleled range of coagulopathy related disorders in affected patients. In this paper, we aim to understand the linkage between abnormal clot formation and the Coronavirus. The clotting parameters of Covid infected patients were studied to elucidate a better understanding of the coagulation disorder. A comparative analysis of the diagnostic reports collected from five different labs across the world aids us comprehend the elevated levels of coagulation parameters observed in these Covid infected patients. Initial coagulopathy of COVID 19 has been characterized as increased levels of prothrombin time, activated partial thromboplastin time, and platelet counts followed by elevated concentrations of D dimer and fibrin degradation products. Coagulation assays used to determine these clotting factors were through invasive methods. Conventional coagulation assays being invasive had their drawbacks taken care of with the advent of non-invasive methods. With the current scenario of this pandemic, the necessity for technological improvements in non-invasive and point of care testing methods are substantial. © 2023 Author(s).